RxDoctor Payments Data

Mark Kronenfeld

Anesthesiology · Brooklyn, NYNPI 1306084389

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.9%), ownership interests and consulting fees — rather than concentrated in one kind of arrangement. Pacira Pharmaceuticals Incorporated accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,445,887in general payments, 2019–2025

Across 147 payments — averaging $16,639 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$2.4M
  • Topera, Inc.$2K

What the payments were for

  • Consulting fees$21,6071%
  • Speaking & faculty fees$1,269,39452%
  • Travel & lodging$6,6580%
  • Food & beverage$7,7250%
  • Gifts$3610%
  • Ownership interest$1,138,90847%
  • Other$1,2350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pacira Pharmaceuticals Incorporated144$2,443,661
Topera, Inc.3$2,226

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,445,887 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.

See all anesthesiology providers in New York

Other anesthesiology in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →